Literature DB >> 6025235

Recurrent ventricular tachycardia and fibrillation treated with a combination of beta-adrenergic blockade and electrical pacing.

L S Cohen, R A Buccino, A G Morrow, E Braunwald.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1967        PMID: 6025235     DOI: 10.7326/0003-4819-66-5-945

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  9 in total

1.  Paroxysmal ventricular tachycardia of unknown etiology.

Authors:  C W Darby
Journal:  Proc R Soc Med       Date:  1975-05

2.  Relationship between heart rate and ventricular ectopic rhythm in acute myocardial infarction.

Authors:  W Merx; K W Heinrich; W Bleifeld; S Effert
Journal:  Klin Wochenschr       Date:  1973-07-01

3.  Treatment of ventricular tachycardia in an infant.

Authors:  J Sanchez; K Christie; G R Cumming
Journal:  Can Med Assoc J       Date:  1972-07-22       Impact factor: 8.262

4.  Long-term control of intractable supraventricular tachycardia by ventricular pacing.

Authors:  E Sowton; R Balcon; T Preston; D Leaver; M Yacoub
Journal:  Br Heart J       Date:  1969-11

5.  Recurrent ventricular fibrillation treated by multiple countershocks.

Authors:  J A Milliken
Journal:  Can Med Assoc J       Date:  1969-02-08       Impact factor: 8.262

Review 6.  Beta-adrenergic receptor blocking drugs in cardiac arrhythmias.

Authors:  B N Singh; D E Jewitt
Journal:  Drugs       Date:  1974       Impact factor: 9.546

7.  Control of refractory ventricular ectopy. Atrial and ventricular overdrive pacing.

Authors:  R Meyer; L B Jacobson
Journal:  West J Med       Date:  1981-06

8.  Suppression of ventricular tachyarrhythmias by transvenous intracardiac pacing after acute myocardial infarction.

Authors:  M A Bennett; B L Pentecost
Journal:  Br Med J       Date:  1970-11-21

9.  Atrial pacing to control heart rate and rhythm in acute cardiac conditions.

Authors:  W G Friesen
Journal:  Can Med Assoc J       Date:  1971-05-22       Impact factor: 8.262

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.